REM sleep and prolactin in patients with non-affective psychoses

Psychoneuroendocrinology

Volumn 27, Issue 6, 2002, Pages 661-669

  Appelberg, Björn ^a   Katila, Heikki ^a   Rimón, Ranan ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Acethylcholine; Dopamine; Non affective psychoses; Polysomnography; Prolactin; Schizophrenia; Serotonin

Indexed keywords

PROLACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LATENT PERIOD; MALE; MANIC DEPRESSIVE PSYCHOSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN SECRETION; RECORDING; REGULATORY MECHANISM; REM SLEEP; SEROTONINERGIC SYSTEM;

CIRCADIAN RHYTHM; DOPAMINE; HUMANS; PROLACTIN; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SLEEP, REM;

EID: 0036072714     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(01)00067-1     Document Type: Article

References (29)

1. Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses
2. A comprehensive psychopathological rating scale
3. Sleep and psychiatric disorders: A meta-analysis
4. Cholinergic imbalance hypothesis of psychoses and movement disorders: Strategies for evaluation
5. Stage 4 sleep in schizophrenia
6. A dopaminergic-cholinergic mechanism in the production of psychotic symptoms
7. Antagonistic effects of physostigmin and methylphenidate in man
8. Anterior pituitary hormone secretion in chronic schizophrenia - An approach to neurohumoral mechanisms
9. Plasma prolactin concentrations and psychopathology in chronic schizophrenia
10. A longitudinal study of EEG sleep in schizophrenia
11. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics
12. Effect of antipsychotic treatment on polysomnographic measures in schizophrenia: A replication and extension
13. REM latency in psychiatric disorders: Polygraphic study on major depression, bipolar disorder-manic, and schizophrenic disorder
14. A factor analytical study of the Comprehensive Psychopathological Rating Scale among patients with anxiety and depressive disorders
15. Serum prolactin levels in unmedicated schizophrenic patients
16. Dopamine antagonism by thioridazine in schizophrenia
17. Development of a schizophrenia scale sensitive to change
18. Cholinergic REM induction test: Muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia
19. Pharmacology of central cholinergic mechanisms and schizophrenic disorders
20. Cholinergic hyperactivity and negative schizophrenic symptoms: A model of cholinergic/dopaminergic interactions in schizophrenia
21. Electroencephalopgraphic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and prior neuroleptic treatment
22. Muscarinic cholinergic-dopaminergic interactions in schizophrenia: Effects of anticholinergic modulation on REM sleep measures
23. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia
24. Circadian and sleep-related endocrine rhythms in schizophrenia
25. The electroenchephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsycotic drugs
26. Abnormal rapid eye movement latencies in schizophrenia